Genetic heterogeneity, discussed above, of the typical genetic mutations that contribute to NRXN1 deletions and PMD is a challenge to investigating genotype–phenotype associations in clinical studies. The gene discussed is NRXN1; the disease is Pelizeaus-Merzbacher spectrum disorder.